Noble BioVentures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
12
- Portfolio
-
1
- Exits
-
8
Noble BioVentures General Information
Description
Noble BioVentures was a venture management group that used to leverages the infrastructure, technical capabilities and executive management talent pool of its commercial services affiliate Noble Life Sciences. The firm was focused on early-stage technology-oriented biomedical firms developing novel therapeutic molecules and treatments, diagnostic products or tools for biomedical research and development. It was founded in 2009 and was based in Gaithersburg, Maryland.
Contact Information
Website
www.noblebioventures.com
Year Founded
2009
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
- Gaithersburg, MD
- United States
Noble BioVentures Investments (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NexImmune | 17-Jul-2014 | Early Stage VC | 000 | Biotechnology | Generating Revenue | 00000 000000000 |
| 0000000000 | 08-Apr-2014 | 0000 00000 | 00000 | Drug Discovery | Product Development | 00000 000000000 |
| 0000000 | 30-Sep-2012 | 00000 00000 | 0000 | Diagnostic Equipment | Generating Revenue | |
| 000000000 00000000 | 21-Sep-2012 | 00000 00000 | 00.000 | Drug Discovery | Clinical Trials - Phase 3 | |
| 00000 0000 0000000 | 30-Mar-2012 | 0000 00000 | 00000 | Biotechnology | Generating Revenue | |
| 0000 000000000000 | 07-Feb-2006 | 00000 00000 | 000.00 | Pharmaceuticals | Out of Business | |
| 000000000 00000000 | 09-Sep-2005 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 3 | |
| 000000 00000000000 | 25-Jan-2005 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
| Aryx Therapeutics | 02-Jun-2004 | Later Stage VC | 0000 | Pharmaceuticals | Out of Business | |
| Soleno Therapeutics | 03-May-2004 | Early Stage VC | 0000 | Other Devices and Supplies | Generating Revenue |
Noble BioVentures Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ConverGene | 01-Dec-2022 | Secondary Transaction - Private | |
| 00000 0000 0000000 | 01-May-2021 | 000000000 00000000 | |
| 00000000000 | 02-May-2019 | 000 | 0000 |
| 0000000 | 21-Feb-2019 | 000000000 00000000 | |
| 000000000 | 14-Feb-2017 | 0000000000 | |
| 000000 00000000000 | 13-Nov-2014 | 000 | 000.00 |
| Predix Pharmaceuticals Holdings | 16-Aug-2006 | Merger/Acquisition | 0000 |
| GeneOhm Sciences | 14-Feb-2006 | Merger/Acquisition | 00000 |
Noble BioVentures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
